When Searching:
Match All Words (AND)
Match Any Words (OR)
Display PROGRAM format
(no Abstracts or Keywords)
FIELD
OPERATOR
SEARCH TERM(S)
All Authors :
contains
doesn't contain
First Author (Last Name) :
contains
doesn't contain
Title :
contains
doesn't contain
Institution :
contains
doesn't contain
Abstract :
contains
doesn't contain
Presentation Date :
equals
greater than
greater than or equals
less than
less than or equals
Sunday, 6/9/2002
Monday, 6/10/2002
Tuesday, 6/11/2002
Wednesday, 6/12/2002
Thursday, 6/13/2002
Keywords :
contains
doesn't contain
12-step program
5-HT2A receptor
abstinence
abuse
abuse liability
abuse-neglect
ACTH
Acute dependence
addiction
ADHD
adolescence
adolescent
adult
adverse event
African American
age
aggression
agonist
AI
AIDS
alcohol
alcoholism
alternative
American Indians
ampa glutamate
amphetamine
anaesthetic
analgesia
anandamide
anesthetic
animal model
antagonism
antagonist
antibody
antidepressant
antinociception
antisocial personality disorder
anxiety
anxiolytic
AP-1
apoptosis
ASI
assessment
attachment styles
attention
autoradiography
avian
behavior
behavior therapy
behavioral naltrexone therapy
behavioral therapy
benzodiazepine
benzoylecgonine
bias
binding
binge
binge cocaine
bipolar disorder
Bipolar Disorder
blending
blood pressure
boarding schools
body temperature
brain
brain stimulation
bremazocine
buprenorphine
buprenorphine tablet
bupropion
burying behavior
C-14 ethanol
c-fos
Ca2+
calcium channel blocker
cannabinoid
cannabis
carboxamido
cardiovascular
caregiving
case management
CBT
cell death
cerebellum
cerebral blood flow
cerebral perfusion deficits
cFOS
chemokine
child behavior
child development
children
choice
chronic
circadian rhythm
clinical
clinical trial
cloves
club drugs
cluster analysis
CNS
cocaine
cocaine abuse
cocaine addiction
cognition
cognitive
cognitive behavior therapy
cognitive deficits
cognitive function
cold pressor test
community
community-based
comorbidity
comparative analysis
compliance
computers
conditioning
conduct disorder
conflict resolution
consequences
contamination
contingency
contingency management
continuing care
coping
cortisol
cost-effectiveness
cotinine
court
crack cocaine
craving
CRH
crime
criminal justice
cross-sensitization
cue
Cultural
currency
CYP
cytokines
d-amphetamine
data analysis
DATOS
decision making
delta
delta9THC
demographic
dependence
depot
depressant
depression
detection
detoxification
development
deviant behavior
diagnosis
diarhea
diazepam
differential rearing
disability
discharge
discounting
discrimination
disorders
diversion
domestic violence
dopamine
dopamine receptors
dose-response
dpamine
driving
drug
drug court
drug discrimination
drug interactions
drug seeking behavior
drug use epidemiology
drug users
drug-seeker behavior
drug-seeking
drug-seeking behavior
drugs
DSM IV
DSM-IV
dual diagnosis
DUSI
dynorphin
eating disorder
ECG
ecstasy
education
EEG
efficacy
eligibility
employment
environment
environmental factors
epdemiology
epidemiology
equilibrium
estrogen
ethnic
ethnicity
ethnography
etiology
euphoria
evaluation
exercise
expectancy
experiment
exposure
factor analysis
family
family history
female
fetal alcohol syndrome
fluorescent PCR
fMRI
FMRI
focus groups
follow-up
follow-up outcomes
food intake
G protein
GABA
GABA pentin
gambling
GBR derivatives
GEE Profile Analysis
gender
gene
gene expression
genetics
genotyping
GHB
GHB gammahydroxybutynole
glutamate
glutamate receptor
group therapy
hair
half-life
hallucinogen
hallucinogens
HDA axis
headache
health
health services
hepatitis
hepatitis C
heritability
heroin
heroin self-administration
HIV
HIV prevention
HIV risk
HIV risk behavior
HIV testing
home collection
homeless
homer proteins
homosexual
hormone
HPA
HPA axis
Hpa axis
human
IDUs
imaging
immune function
immunity
immunization
immuno suppression
immunosuppression
impoverishment
impulsivity
in vitro
in vivo
incentive
INDIVIDUAL DIFFERENCES
inernet use
infant
infection
infusion
inhalant
inhibition
initiation
injection
injection drugs
injury
inpatient
integrated treatment
intervention
intravenous
ion channel
irreversible antagonist
IRT
isradipine
juvenile justice
kappa
knockout
kreteks
LAAM
laboratory
language
law enforcement
learning
legal
leukocyte
LH
life experiences
ligand binding
linkage
liver
liver function
lobeline
locomotion
locomotor activity
lofexidine
long-term outcomes
longitudinal research
longitundinal
lung cancer
luteinizing hormone
macrophage
maintenance
male
male partner
managed care
MAO-B inhibator
marijuana
marijuana use
marker
matching law
mathematical models
MCPP
MDMA
measurement
mechanical pressure test
medical care
medication development
medicinal chemistry
mehtadone maintenance
melatonin
memory
menstrual cycle
mental disorders
mesolimbic
metabolism
metabolite
metabotropic
methadone
methadone maintenance
methamphetamine
methodology
methylphenidate
mice
microarray
microdialysis
mixtures
mobile services
model
monkey
monoclonal antibody
mood
morphine
mother
motivation
motor activity
mouse
MRI/MRS
mRNA
mu
mu opioid
mu-opioid agonist
mult VI schedule
multi-site
N-acetylserotonin
naloxone
naltrexone
Native American
natrindole
needle exchange
neighborhood
nelfinavir
neuroendocrine
neuropeptide
neurophysiology
neuropsychological function
neuropsychology
neurotransmitter
nicotine
nicotine abuse
nicotinic
nicotinic receptor
nitric oxide
NMDA
NMDA receptor
non-drug reinforcers
non-treatment
norepinephrine
nosology
nucleus accumbens
offender
office-based
open field
operant behavior
opiate
opiates
opioid
opioid detoxification
opportunity
outcome
outcome monitoring
outcome monitoring systems
outcome monitory systems
outpatient
outreach
overdose
oxycodone
oxycontin
pain
paraphernalia
parenting
pathological gamblers
peer pressure
pentobarbital
perception
perinatal
pernatal cocaine
personality
personality disorder
PET
pharmacist
pharmacodynamic
pharmacokinetics
pharmacologic
pharmacology
pharmacoogy
pharmacotherapy
phencyclidine
photic stimulation
physical dependence
physiology
place condition
place preference
PMMA
policy
polydrug abuse
polydrugs
polydrugs/drug interactions
polymorphism
polysubstance abuse
postnatal environment
practitioner
predictor
prefrontal cortex
pregnancy
prenatal
prescription
pretreatment
prevalence
prevention
primary care
primate
priming
prison
probation
productivity
progesterone
progression
progressive ratio
prolactin
prostitution
protein kinase
psychiatric
psychiatric comorbidity
psychiatry
psychometric
psychopathology
psychosocial
psychostimulants
psychotherapy
psychotic disorder
PTSD
public health
PUFAs
pulse
qualitative
quality
quality of life
questionnaire
quitting
quitting rates
race
radioligand
randomised
randomized
rat
rat strains
rating scales
readmission
real time PCR HIV
receptor
recovery
recruitment
reinforcement
reinstatement
relapse
replacement therapy
research to practice
research-based
residential
residential treatment
respiratory depression
retention
review
reward
rhesus monkey
Rho kinase
risk
risperidone
RNase protection assay
route of administration
saccharin preference
safety
salicylate
SAR
schild regression
schizophrenia
schools
screening
selective breeding
self report
self-administration
self-medication
self-report
sensitization
serotonin
services
sex
sex differences
sexual abuse
sexual behavior
sexually transmitted disease
sigma receptor
sleep
slow-release
smoking
smoking cessation
social network
social phobia
social support
socioeconomic status
solvent
somatostatin receptor
spect
speedball
spirituality
sprituality
squirrel monkey
SR-141716
stabilization
staff
step care
stereotypy
stimulant
strain differences
stress
striatum
subjective effects
substance abuse
substance abuse treatment
substance abuse treatment patients
substance abuse treatment staff
substance dependence
substance P
substance use disorder
substance use problems
substance use severity
substane abuse
substitution
substitution treatment
subtypes
SUD
suicide
survey
survival analysis
sweat
symptom
synthesis
system focus groups
TaqMan
taste aversion
technology
teenage smokers
TES
test development
thalamus
THC
therapeutic communities
therapeutic relationship
therapeutic trials
thrombosis
tiagabine
timing
tobacco
tolerance
toxicity
toxicology
trail-making test
transgender
transporter
trauma
treatment
treatment matching
treatment outcome
treatment practices
treatment response
trend
tropane
twins
UDS
urinalysis
vaccine
validity
vanilloid
vasoconstriction
ventral tegmental area
violence
voucher
vulnerability
weight
welfare
withdrawal
withdrawal symptoms
women
women and gender
young adult
young adults
Workshops:
contains
doesn't contain
Getting Collaborative International Research Off the Ground
Human Abuse Liability
: Research and Drug Development Challenges
Whats New At NIDA And NIH: How Will it Affect You?
Grant-Writing Workshop
NIDA Med. Develop.:New Directions and Resources For Medicinal Chemists
Career Development
Circumnavigating the Globe with Buprenorphine
Epidemiology and Biostatistics Research Methods
Symposia:
contains
doesn't contain
Is Dopamine The Answer? Evidence for the Importance of Other Systems
Substances of Abuse and the Pathogenesis of HIV
Mediating Role of Parental Cognitionsin
Parenting Processes
Drug Reward in Humans: What Does Dopamine Do?
Abuse-Relevant Behavioral Effects of Drugs:
Young Investigators
GHB: Chemical, Biochemical, and Behavioral Effects
Prescription Drug Abuse: Everything Old is New Again
Cocaine Addiction: To the Amygdala and Beyond
Longitudinal Studies of Pathways to Drug Abuse:
Violence Exposure and Substance Abuse
Neuropeptidergic Responses to Psychostimulant Drugs
:Drug Dev.
The New New Thing: Applying Info. Tech. to Drug Abuse
Treatment
French Experience with Buprenorphine
Drug Choice: What We Know and What We Need to Know
Other Sessions:
Plenary Session
Marian W. Fischman Memorial Award Lecture
Graduate Student Mixer
Early Career Investigator Awards Luncheon
Business Meeting
Contingency Management Working Group
Society For Adolescent Substance Abuse Treatment Effectiveness (SASATE)
Training Grant Mixer
Late-Breaking Research News
Special Lecture-John P. Walters, ONDCP
Dinner and Dancing
Brunch With Champions
Oral Communications:
I: Drugs and Bugs and Viruses, O My!
II: Users in Utero
III: Attention to Prevention
IV: Getting Off Your High Horse
V: Cue and a on Craving
VI: Social Treatment Issues
VII: Better Living Through Chemistry
VIII: All Aboard for Gland Central!
IX: Cannabis-Ness
X: This is Your Brain on Drugs!
XI: What a Relief!
XII: Bits, Bytes and Drugs
XIII: Cocaine: Reinforcing Fx
XIV: Cocaine: XX vs. XY
XV: Nico-Teen
XVI: Epidemiology
XVII: Opiates and Operants
XVIII: The Agony of Ecstasy
XIX: Absence and Withdrawal
XX: Core, Techs and Drugs
XXI: Double Trouble: Dual Diagnosis
XXII: Pluses and Minuses of Neurotransmission: Glutamate and Gaba
XXIII: Whats New?